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Abstract: 
The present study examined the predictive validity of psychometrically assessed positive and 
negative schizotypy in the Chapmans’ 10-year longitudinal data set. Schizotypy provides a 
useful construct for understanding the etiology and development of schizophrenia and related 
disorders. Schizotypy and schizophrenia share a common multidimensional structure that 
includes positive and negative symptom dimensions. Recent cross-sectional studies have 
supported the validity of psychometric positive and negative schizotypy; however, the present 
study is the first to examine the predictive validity of these dimensions. The Chapmans’ 
longitudinal data provided an ideal opportunity because of the large sample size, high 
reassessment rate, and extended interval between assessments. A total of 534 psychometric high-
risk and control participants were initially assessed, and 95% of this sample was reinterviewed 
10 years later. As hypothesized, positive and negative schizotypy uniquely predicted the 
development of schizophrenia-spectrum disorders. At the reassessment, both positive and 
negative schizotypy predicted psychotic-like, schizotypal, and paranoid symptoms, as well as 
poorer adjustment. The positive dimension was associated with mood and substance use 
disorders and mental health treatment. Negative schizotypy was associated with schizoid 
symptoms and social impairment at the follow-up. The results extend the growing validity 
findings for psychometrically assessed positive and negative schizotypy by demonstrating that 
they are associated with the development of differential patterns of symptoms and impairment. 
Keywords: Psychopathology | Psychosis | Negative schizotypy | Positive schizotypy | Psychosis-
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Article: 
As schizotypy enters its sixth decade, it remains a valuable and evolving construct for 
considering individual differences and specifically for understanding vulnerability for 
schizophrenia-spectrum psychopathology ( Claridge, 1997; Lenzenweger, 2010; Meehl, 
1962, 1990; Rado, 1956). Since the time of Paul Meehl’s landmark address to the American 
Psychological Association in 1962, schizotypy has evolved from a relatively homogenous 
phenotype linked to a single-gene model of liability for schizophrenia to a broader, 
multidimensional construct. Although the exact nature of schizotypy is not universally agreed on 
(see landmark texts by Claridge [1997] and Lenzenweger [2010] for opposing viewpoints), we 
conceptualize schizotypy as a continuum of schizophrenia-like manifestations ranging from 
minimal impairment, to subclinical deviance, to personality pathology, to full-blown psychosis 
( Kwapil, Barrantes-Vidal, & Silvia, 2008). Thus, schizotypy conveys the vulnerability for 
schizophrenia-spectrum disorders, although the majority of schizotypic individuals are not 
expected to develop psychosis. The study of schizotypy is useful for understanding the etiology 
and development of schizophrenia and related disorders, in part because it avoids third-variable 
confounds such as medication, stigma, and institutionalization arising from schizophrenia. The 
reliable identification of schizotypic individuals should facilitate our understanding of relevant 
etiological factors and developmental trajectories, clarify risk and protective agents, and provide 
a necessary step toward development of preventative treatments. 
Schizotypy and, by extension, schizophrenia are heterogeneous. This heterogeneity occurs at the 
phenotypic level, with symptoms and impairment ranging from marked diminution (e.g., alogia) 
to marked excesses (e.g., hallucinations) in behavior. Furthermore, this heterogeneity is evident 
at the etiological, developmental, and treatment-response levels. Thus, treating schizotypy and 
schizophrenia as homogenous constructs impedes our ability to understand the origins, 
development, and expression of these complex conditions ( Kwapil & Barrantes-Vidal, 2012). 
The heterogeneity of schizotypy and schizophrenia appear to be characterized by a common 
multidimensional structure. Factor analytic studies suggest that positive, negative, and 
disorganized dimensions underlie schizophrenia (Lenzenweger & Dworkin, 1996; Liddle, 1987). 
Consistent with the factor structure of schizophrenia, positive and negative factors of schizotypy 
are the most replicated dimensions ( Cicero & Kerns, 2010; Kwapil et al., 2008; Vollema & van 
den Bosch, 1995). The reliable identification and measurement of these dimensions is essential 
for parsing the heterogeneity of schizotypy and schizophrenia. 
Recent research indicates that two factors underlie the Wisconsin Schizotypy Scales, which are 
comprised of the Perceptual Aberration ( Chapman, Chapman, & Raulin, 1978), Magical 
Ideation ( Eckblad & Chapman, 1983), Physical Anhedonia ( Chapman, Chapman, & Raulin, 
1976), and Revised Social Anhedonia ( Eckblad, Chapman, Chapman, & Mishlove, 1982) 
Scales. Exploratory and confirmatory factor analyses reliably identify positive and negative 
schizotypy dimensions that account for approximately 80% of the variance in the measures 
(e.g., Lewandowski et al., 2006; Brown, Silvia, Myin-Germeys, Lewandowski, & Kwapil, 
2008; Kwapil et al., 2008). This factor structure has been replicated in cross-cultural studies 
(e.g., Kwapil, Ros-Morente, Silvia, & Barrantes-Vidal, 2012). Furthermore, studies indicated 
that the positive and negative schizotypy dimensions are associated with differential patterns of 
symptoms and impairments in cross-sectional questionnaire studies (e.g., Lewandowski et al., 
2006), interview studies (e.g., Kwapil et al., 2008; Barrantes-Vidal et al., 2013), laboratory 
studies ( Kaczorowski, Barrantes-Vidal, & Kwapil, 2009), and experience sampling studies 
(e.g., Kwapil, Brown,Silvia, Myin-Germeys, & Barrantes-Vidal, 2012). Consistent with deficits 
reported in positive and negative symptom schizophrenia, Kwapil et al. (2008) indicated that the 
positive and negative schizotypy dimensions were differentially related to psychopathology, 
personality, and social functioning. Both schizotypy dimensions were associated with 
schizotypal and paranoid personality disorder symptoms. Positive schizotypy was uniquely 
related to psychotic-like experiences, substance abuse, mood disorders, and mental health 
treatment, whereas negative schizotypy was specifically associated with negative and schizoid 
symptoms. Both dimensions were associated with poorer overall and social functioning, but 
negative schizotypy was associated with decreased likelihood of intimate relationships. 
Furthermore, Barrantes-Vidal et al. (2013) indicated that the schizotypy dimensions are 
associated with prodromal symptoms in a nonclinically identified sample. 
These initial findings support the construct validity of psychometrically assessed positive and 
negative schizotypy dimensions. However, this work has been limited to cross-sectional studies. 
The present study examined the predictive validity of the schizotypy dimensions using data from 
the Chapmans’ 10-year longitudinal study of psychosis proneness (e.g., Chapman, 
Chapman, Kwapil, Eckblad, & Zinser, 1994; Kwapil, 1998). The Chapmans’ study was the first 
longitudinal assessment of psychometric high risk and it was notable for its large sample, high 
reassessment rate, and 10-year follow-up interval. They interviewed 534 college students at the 
initial assessment and reassessed 95% of the sample 10 years later. The study used a 
psychometric high-risk approach in which participants were assigned to five groups: (1) high 
scorers on Perceptual Aberration or Magical Ideation (PerMag) Scales, (2) high scorers on the 
Impulsive-Nonconformity Scale ( Chapman et al., 1984), (3) high scorers on the Physical 
Anhedonia Scale, (4) a combined-risk group, and (5) a control group. However, the study did not 
examine the dimensional structure underlying the psychometric measures. 
At the cross-sectional assessment, the high-risk groups exceeded the control participants on 
psychotic-like experiences and schizotypal symptoms. Chapman et al. (1994)noted that the 
PerMag group was especially deviant. Note that none of the participants were psychotic at the 
time of the initial assessment. At the 10-year reassessment, 14 participants had developed DSM–
III–R ( American Psychiatric Association, 1987) psychotic disorders and 30 met criteria for 
schizophrenia-spectrum disorders including schizotypal, schizoid, and paranoid personality 
disorders. The PerMag group exceeded the control group on rates of psychotic disorders, as well 
as on ratings of psychotic-like, schizotypal, and paranoid symptoms. They also had poorer 
overall functioning and elevated rates of mood and substance use disorders. None of the other 
groups exhibited elevated rates of psychotic disorders. Although participants in the longitudinal 
study were not selected based on scores on the Revised Social Anhedonia Scale, Kwapil (1998) 
reported that scores on the scale predicted elevated rates of schizophrenia-spectrum disorders, as 
well as psychotic-like, schizotypal, schizoid, and paranoid symptoms. 
The primary goal of the present study was to investigate the predictive validity of 
psychometrically assessed positive and negative schizotypy using data from the Chapmans’ 
longitudinal study. The validity of these dimensions has been supported in a variety of cross-
sectional studies, but this provided the first examination of their predictive validity. This 
longitudinal data set provides an ideal vehicle for this purpose. Based on cross-sectional findings 
(e.g., Kwapil et al., 2008; Gross, Silvia, Barrantes-Vidal, & Kwapil, 2013), it was hypothesized 
that the positive and negative schizotypy dimensions would predict differential patterns of 
psychopathology and impairment at both assessments. Specifically, it was hypothesized that both 
dimensions would predict schizotypal and paranoid symptoms and functional impairment. 
Further, it was expected that positive schizotypy would predict psychotic-like experiences, mood 
disorder symptoms, and substance abuse at both time points and that negative schizotypy would 
predict schizoid symptoms. Most importantly, it was hypothesized that both dimensions would 
predict the development of schizophrenia-spectrum disorders at the reassessment. 
Method 
Participants 
The present study used data from the Chapmans’ longitudinal study of psychosis-proneness. The 
method is described below, but additional details can be found in Chapman et al. 
(1994) and Kwapil (1996, 1998). 
Initial assessment 
A total of 534 students enrolled at the University of Wisconsin-Madison participated in the initial 
assessment (mean age = 19.3 years, SD = 1.4; 52% female). These participants were initially 
selected from a pool of approximately 8,000 undergraduates who completed the Wisconsin 
Schizotypy Scales in mass screening sessions over the course of seven semesters. High-risk 
participants were recruited based on standard scores of at least 1.96 on the Perceptual Aberration 
or Magical Ideation Scales ( n = 193), Physical Anhedonia Scale ( n = 75), or Impulsive-
Nonconformity Scale ( n = 74). A combined risk group included 33 participants whose sum of 
their standard scores on the four scales was at least 3.0. Additionally, 159 control participants 
were included who had standard scores on each of the four scales of less than 0.5. Note that 
consistent with our hypotheses there was not any group assignment used in the present study or 
any group comparisons conducted. 
10-year follow-up assessment 
A total of 508 of the original participants (95%) were reinterviewed (mean age = 30.0 
years, SD = 1.7; 52% female). Participants who completed the reassessment did not differ from 
those lost to attrition on positive and negative schizotypy scores. The mean interval between the 
assessments was 10.7 years ( SD = 1.0). The positive and negative schizotypy dimensions were 
unassociated with interval length ( rs = −.04 and .06, respectively). 
Materials and Procedures 
Initial assessment 
The 534 participants who took part in the initial assessment completed face-to-face interviews 
and were administered the Revised Social Anhedonia Scale and a questionnaire measure of 
paranoia that contained 36 true/false items, including 10 items from the Minnesota Multiphasic 
Personality Inventory Scale 6 ( University of Minnesota, 1943). 
The structured interview included the Schedule for Affective Disorders and Schizophrenia–
Lifetime version (SADS-L; Spitzer & Endicott, 1977) sections covering mood, psychotic and 
substance use disorders, and schizotypal features. The SADS-L was modified to obtain 
additional information about psychotic-like experiences. The Wisconsin Manual for Assessing 
Psychotic-like Experiences ( Chapman & Chapman, 1980; Kwapil, Chapman, & Chapman, 
1999) was used to quantify seven classes of psychotic symptoms across a range of clinical and 
subclinical deviancy. Kwapil et al. (1999) reported that the highest rating across the seven 
classes provides a useful index that predicts the development of psychotic disorders. Each 
participant’s rating of schizotypal symptoms was the total number of the 18 criteria endorsed. 
The Social Adjustment Scale interview ( Weissman & Paykel, 1974) was used to quantify social 
impairment. It produced a total score and subscale scores for social functioning in school, social 
and leisure, and family settings (with higher scores indicating greater impairment). Participants 
were assessed for substance use disorders and assigned quantitative ratings of impairment 
associated with drug and alcohol use ( Kwapil, 1996). 
10-year follow-up assessment 
The follow-up interview assessed overall functioning, psychosis, schizophrenia-spectrum 
personality disorders, psychotic-like experiences, mood disorders, substance abuse, and mental 
health treatment. Note that the Wisconsin Schizotypy Scales were not readministered at the 
follow-up assessment. The interview included a modified SADS-L, the Wisconsin Manual for 
Assessing Psychotic-like symptoms, and portions of Loranger’s (1988) Personality Disorder 
Exam (PDE) that assessed schizotypal, schizoid, and paranoid personality disorders. The PDE 
provided both DSM–III–R diagnoses and dimensional ratings of the disorders. The Global 
Adjustment Scale ( Endicott, Spitzer, Fleiss, & Cohen, 1976) was used to assess overall 
functioning for each subject. Participants were rated on a six-point scale of the closeness and 
quality of intimate relationships. Substance use was assessed in the same manner as at the initial 
interview. 
The interviews, as well as the scoring and diagnosis at both assessments, were conducted by 
clinical psychologists and advanced graduate students who had received extensive diagnostic 
training. Interviewers and raters at both assessments were unaware of the subjects’ scores on the 
schizotypy scales. Interviewers and raters at the follow-up were unaware of participants’ 
responses at the initial assessment. 
Results 
Schizotypy Dimension Scores 
Positive and negative schizotypy dimension scores were computed for all 534 participants in the 
10-year follow-up study. Schizotypy scores were assigned based on formulae derived from a 
principal components analysis with a promax rotation of the four Wisconsin Schizotypy Scales 
using the sample of 6,137 young adults described in Kwapil et al. (2008). Note that this factor 
structure accounts for 80% of the variance in the Wisconsin Schizotypy Scales, correlates .99 
with confirmatory factor analytic derived scores fromKwapil et al., and appears invariant across 
samples. This is the same procedure used in other studies from our laboratory examining the 
differential expression of positive and negative schizotypy dimensions (e.g., Barrantes-Vidal et 
al., 2013; Kaczorowski et al., 2009; Kwapil, Brown, et al., 2012). The formulae (based on raw 
scores on the scales) are as follows: 
Positive schizotypy = (Perceptual Aberration * 0.091) 
+ (Magical Ideation * 0.092) 
+ (Physical Anhedonia * − 0.018) 
+ (Social Anhedonia * 0.027) − 1.386 
Negative schizotypy = (Perceptual Aberration * 0.006) 
+ (Magical Ideation * − 0.008) 
+ (Physical Anhedonia * 0.089) 
+ (Social Anhedonia * 0.096) − 1.936 
Consistent with the selection process for the longitudinal study, the mean for the positive 
schizotypy dimension was higher than for the negative schizotypy dimension; however, the 
range of scores was comparable for the two dimensions (Positive schizotypy: M = .95, SD = 
1.53, range = −1.96 to 4.63; Negative schizotypy: M = −.27, SD = 1.05, range = −1.85 to 4.91). 
The two dimensions were modestly inversely correlated, r = −.23, p < .001. The positive and 
negative schizotypy dimensions were uncorrelated with age at each assessment, and with 
parental socioeconomic status measured at the initial assessment. The positive schizotypy 
dimension scores were significantly higher in women (women: M = 1.17, SD = 1.48; men: M = 
.72, SD = 1.56, p < .01, Cohen’s d = .30), and the negative schizotypy dimension scores were 
significantly higher in men (women: M = −.47, SD = .93; men: M = −.04, SD = 1.12, p < .001, 
Cohen’s d = .49). 
Associations of Positive and Negative Schizotypy at the Initial Assessment 
In order to assess the validity of the schizotypy dimensions, a series of hierarchical linear and 
binary logistic regression analyses were computed examining the variance accounted for by the 
positive and negative schizotypy dimensions and their interaction in the prediction of measures 
of psychopathology and functioning at the initial and 10-year follow-up assessments. The 
positive and negative schizotypy dimensions were entered simultaneously in the regression at the 
first step to examine the relative contribution of each factor. The interaction term was entered at 
the second step to assess its effect over-and-above the main effects. Note that the Chapman et 
al.’s (1994) longitudinal study initially used an extreme groups design. However, we believe that 
regression analyses are appropriate because (a) there were continuous and uninterrupted 
distributions for the four Wisconsin Schizotypy Scales in the Chapman et al. study, (b) positive 
and negative schizotypy factor score assignments were based on a large unselected sample, and 
most importantly, (c) the distributions of the positive and negative schizotypy dimensions were 
continuous and uninterrupted. Given that a number of the variables had non-normal distributions, 
bootstrap procedures with 10,000 samples were used for the linear regression analyses. Note that 
statistical significance for linear regression analyses was only indicated at the .05 and .01 level, 
because Mplus does not provide bootstrap confidence interval (CI) levels for the upper and lower 
.05% cutoffs. 
Schizophrenia-spectrum psychopathology and functioning 
Table 1 presents the linear and logistic regressions at the initial assessment. Positive schizotypy 
was associated with ratings of psychotic-like, schizotypal, and paranoid symptoms. Negative 
schizotypy was associated with schizotypal and paranoid symptoms. The positive × negative 
schizotypy interaction predicted paranoid symptoms over-and-above the main effects. Simple 
slopes analysis of the interaction term revealed that positive schizotypy significantly predicted 
paranoid symptoms at all levels of negative schizotypy, but this relation strengthened as negative 
schizotypy increased. This was the case for low (β = 0.38), moderate (β = 0.51), and high (β = 
0.64, all slopes p < .001) levels of negative schizotypy (low reflects −1 SD, moderate is the 
mean, and high is +1 SD). Both positive and negative schizotypy dimensions were associated 
with impaired functioning as assessed by the Social Adjustment Scale total and subscale scores.  
 
Table 1 Linear and Logistic Regressions of Measures at the Initial Assessment ( n = 534) 
Multiple linear regressions with 10,000 bootstrap samples 
 Step 1 Step 2 
 Positive schizotypy Negative schizotypy Interaction 
Dependent β Δr2 β Δr2 β Δr2 
variable 
Highest 
psychotic-like 
experience 
.469** .209 .040 .002 .041 .002 
Schizotypal 
symptoms 
.529** .265 .160** .024 .061 .003 
Paranoia 
questionnaire 
.518** .254 .227** .049 .140** .018 
Social 
Adjustment 
Scale: total 
.241** .055 .402** .153 .059 .003 
Social 
Adjustment 
Scale: school 
.140** .018 .114** .012 .096* .009 
Social 
Adjustment 
Scale: leisure 
.177** .030 .451** .192 .061 .003 
Social 
Adjustment 
Scale: family 
.287** .078 .305** .088 .001 .000 
RDC depressive 
symptoms 
.341** .110 .016 .000 .086 .007 
RDC mania 
symptoms 
.278** .073 .020 .000 .020 .000 
Impairment from 
alcohol use 
.188** .034 .042 .002 .028 .001 
Impairment from 
drug use 
.145** .020 .032 .001 .050 .002 
Binary logistic regressions 
 Step 1 Step 2 
 Positive schizotypy Negative schizotypy Interaction 
Dependent 
variable 
OR 95% CI OR 95% CI OR 95% CI 
Alcohol 
abuse/dependence 
1.22* 1.03, 1.45 1.10 0.86, 1.40 0.98 0.78, 1.23 
Drug 
abuse/dependence 
1.31** 1.11, 1.56 0.88 0.67, 1.15 1.10 0.85, 1.42 
Note. RDC = Research Diagnostic Criteria; OR = odds ratio; CI = confidence interval. *p < .05. 
** p < .01. 
Mood symptoms and substance abuse 
As hypothesized, positive, but not negative, schizotypy was associated with mood disturbances 
and substance abuse. Positive schizotypy was associated with increased ratings of depressive and 
manic symptoms. In addition, it was associated with elevated rates of substance use disorders 
and with quantitative ratings of impairment associated with alcohol and drug use. 
Associations of Positive and Negative Schizotypy at the Reassessment 
Schizophrenia-spectrum psychopathology 
Table 2 presents the linear and logistic regressions of positive and negative schizotypy at the 
initial assessment predicting outcomes at the 10-year follow-up assessment. Positive schizotypy 
was associated with the development of psychotic disorders at the follow-up, whereas both 
positive and negative schizotypy were significantly associated with the development of 
schizophrenia-spectrum disorders (including both psychotic disorders and cluster A personality 
disorders). Note that the odds ratios (ORs) for the prediction of psychotic disorders were 
comparable for positive and negative schizotypy, but only attained statistical significance for 
positive schizotypy. This may reflect that the sample had a higher rate of high scorers on positive 
than on negative schizotypy and thus provided a more stable estimate of the effects for positive, 
than for negative, schizotypy. Both schizotypy dimensions were associated with ratings of 
psychotic-like experiences and schizotypal and paranoid personality traits. In addition, negative 
schizotypy was associated with ratings of schizoid personality traits. Consistent with the initial 
interview, the positive × negative schizotypy interaction predicted paranoid traits. Simple slope 
analysis revealed that the relation between positive schizotypy and paranoid personality traits 
was significant at moderate (β = 0.22; p < .001) and high (β = 0.35; p < .001) levels of negative 
schizotypy, but not at low levels (β = 0.094).  
 
Table 2 Linear and Logistic Regressions of Measures at the 10-Year Follow-Up ( n = 508) 
Multiple linear regressions with 10,000 bootstrap samples 
 Step 1 Step 2 
 Positive schizotypy Negative schizotypy Interaction 
Dependent 
variable 
β Δr2 β Δr2 β Δr2 
Highest 
psychotic-like 
experience 
.369** .127 .090* .008 .103 .010 
Paranoid 
personality rating 
.224** .047 .160** .024 .137* .017 
Schizotypal 
personality rating 
.325** .099 .189** .034 .083 .006 
Schizoid 
Personality rating 
.005 .000 .260** .064 −.054 .003 
Global 
adjustment scale 
−.268** .068 -.124** .015 −.072  .005 
Relationship 
closeness 
−.040 .002 −.208** .041 −.052 .002 
Impairment from 
alcohol use 
.118* .013 .061 .003 .018 .000 
Impairment from 
drug use 
.243** .056 −.070 .005 .016 .000 
Binary logistic regressions 
 Step 1 Step 2 
 Positive schizotypy Negative schizotypy Interaction 
Dependent 
variable 
OR 95% CI OR 95% CI OR 95% CI 
Any psychotic 
disorder 
1.49* 1.04, 2.13 1.49 0.95, 2.35 1.21 0.79, 1.85 
Any 
schizophrenia-
spectrum disorder 
1.50** 1.16, 1.94 1.87*** 1.37, 2.55 1.02 0.77, 1.35 
Ever married 0.93 0.82, 1.04 0.74** 0.62, 0.89 0.88 0.73, 1.06 
Any mental 
health treatment 
1.17* 1.03, 1.32 0.85 0.71, 1.02 1.06 0.88, 1.27 
Major depressive 
episode 
1.37*** 1.20, 1.58 1.00 0.81, 1.23 1.19 0.96, 1.49 
Manic/hypomanic 
episode 
1.82*** 1.34, 2.47 1.30 0.87, 1.95 0.91 0.65, 1.30 
Any suicide 
attempt 
1.58* 1.11, 2.27 0.91 0.52, 1.60 1.67 0.93, 3.01 
Alcohol 
abuse/dependence 
1.19* 1.02, 1.38 1.13 0.91, 1.40 0.99 0.80, 1.22 
Drug 
abuse/dependence 
1.25** 1.06, 1.48 0.87 0.66, 1.14 1.09 0.84, 1.42 
Note. OR = odds ratio; CI = confidence interval.* p < .05. ** p < .01. *** p < .001. 
The same interview measure of psychotic-like experiences was administered at both assessments 
and correlated .36 across the two interviews. In order to examine whether the schizotypy 
dimensions predicted worsening psychotic-like experiences across the 10-year interval, we 
recomputed the regression analysis predicting psychotic-like experiences at the follow-up after 
partialing out variance associated with psychotic-like experiences at the initial interview. The 
prediction of follow-up psychotic-like experiences remained significant for both positive (β = 
0.25; p < .001) and negative (β = 0.08; p < .05) schizotypy. Although different measures were 
used at the two assessments, the correlations across assessments of ratings of schizotypal ( r 
= .34) and paranoid ( r = .34) symptoms were significant. We recomputed the regression 
analyses partialing out the baseline measures. The prediction of schizotypal symptoms remained 
significant for both positive (β = 0.20; p < .001) and negative (β = 0.15; p < .01) schizotypy. 
Likewise, the prediction of paranoid symptoms remained significant for both positive (β = 
0.10; p < .05) and negative (β = 0.11; p < .05) schizotypy. 
Functioning and mental health treatment 
Both positive and negative schizotypy predicted impaired functioning as assessed by the Global 
Adjustment Scale. Negative, but not positive, schizotypy was associated with diminished 
closeness of significant relationships and with diminished likelihood of having married. Positive 
schizotypy was associated with increased likelihood of receiving mental health treatment 
(including hospitalization, pharmacotherapy, or psychotherapy). 
Mood disorders and substance abuse 
As hypothesized, positive, but not negative, schizotypy was associated with mood disturbances 
and substance abuse. Positive schizotypy was associated with increased likelihood of major 
depressive and manic or hypomanic episodes, as well as with increased rates of suicide attempts. 
Family members indicated that two participants committed suicide between the initial and 
follow-up assessments. Both of these participants had elevated scores on the positive, but not the 
negative, schizotypy dimension (positive schizotypy standard scores of 2.48 and 2.65). Positive 
schizotypy was associated with elevated rates of substance abuse and dependence disorders and 
with quantitative ratings of impairment associated with alcohol and drug use. 
As hypothesized, the positive and negative schizotypy dimensions were associated with 
differential patterns of symptoms and impairment. However, one question is whether the 
dimensions actually perform better than the original group assignment. Therefore, we reran the 
regression analyses for five primary dependent measures at the 10-year follow-up (global 
adjustment, psychotic-like experiences, and schizotypal, schizoid, and paranoid personality 
disorder symptoms) after partialing out variance associated with group membership. Specifically, 
we created four dummy codes that compared Chapman et al.’s (1994) Perceptual 
Aberration/Magical Ideation, Physical Anhedonia, Impulsive-Nonconformity, and combined 
groups with the control group, following guidelines from Cohen, Cohen, West, and Aiken 
(2003). We entered the dummy codes as a block in the regression analysis prior to entering the 
schizotypy dimension scores. The findings for the positive and negative schizotypy dimensions 
were unchanged (negative schizotypy still significantly predicted all five criteria and positive 
schizotypy significantly predicted all the criteria except schizoid symptoms). In contrast, almost 
none of the dummy codes remained significant after entering the schizotypy dimensions. 
Post Hoc Analyses 
We conducted a number of post hoc analyses in response to recommendations of the reviewers to 
further examine the nature of the associations of positive and negative schizotypy with outcomes 
at the assessments. First, we examined whether the schizotypy dimensions predicted psychotic or 
schizophrenia-spectrum disorders at the follow-up assessment over-and-above the effects of 
family history of psychosis in first degree relatives. Note that 15 participants reported a first-
degree relative with psychosis, and neither the positive schizotypy nor negative schizotypy 
dimensions were associated with family history, r = −.03 and .06, respectively. In each logistic 
regression analysis family history of psychosis in a first-degree relative was entered at Step 1, 
and the schizotypy factors were entered together at Step 2. Family history significantly predicted 
psychotic disorders at the follow-up assessment, OR = 6.17, 95% CI [1.25, 30.40], p < .05. 
Furthermore, positive schizotypy still predicted psychotic disorders, OR = 1.53, 95% CI [1.06, 
2.20], p < .05, although negative schizotypy did not, OR = 1.47, 95% CI [0.92, 2.33]. Similarly, 
family history significantly predicted schizophrenia-spectrum disorders at the follow-up 
assessment, OR = 6.53, 95% CI [1.95, 21.92], p < .01. Both positive schizotypy, OR = 1.53, 95% 
CI [1.18, 1.99], p < .01, and negative schizotypy, OR = 1.86, 95% CI [1.35, 2.56], p< .001, still 
predicted spectrum disorders over-and-above family history. 
Given that the Chapmans’ original sample was initially selected using an extreme groups 
approach, a reviewer recommended analyses of weighted data to correct for sampling bias. 
Therefore, we computed a sampling weight for each subject based on the product of the 
probability of their positive and negative schizotypy scores (using norms from our original 
derivation sample). We then recomputed the regression analyses for our primary schizotypy-
dependent measures at the follow-up (Global Assessment of Functioning score, psychotic-like 
experiences, schizotypal, schizoid, and paranoid personality dimensional scores) using the Mplus 
WEIGHT option. The results were substantively unchanged, with the exception that negative 
schizotypy no longer significantly predicted psychotic-like experiences at the follow-up 
assessment. These results are presented in Supplemental Table S1. 
We also calculated the prediction of quantitative outcome measures at the initial and follow-up 
assessment separately for the positive and negative schizotypy factors (as opposed to our planned 
analyses that entered them simultaneously into the regression models). Note that the statistical 
significance of these zero-order associations was largely unchanged from the initial regressions. 
These results are reported in Supplemental Table S2. 
Following a reviewer’s recommendation, we recalculated all of the linear and logistic regressions 
after removing variance associated with gender. Note that in every reanalysis, gender (coded 1 = 
men, 2 = women) was entered at the first step, and the positive and negative schizotypy 
dimension scores were entered simultaneously at the second step. Note that none of the effects 
for positive and negative schizotypy were substantively changed after partialing out variance 
associated with gender (see Supplemental Table S3). Thus, although there are gender differences 
in positive and negative schizotypy, the cross-sectional and longitudinal predictions of 
psychopathology and impairment by psychometric schizotypy were not accounted for by gender. 
The primary goal of the study was to examine the association of the positive and negative 
schizotypy dimensions with symptoms and impairment at the initial and 10-year follow-up 
assessments. However, a reviewer raised concerns about the need to test the relative predictive 
strength of the two schizotypy dimensions (i.e., whether the positive and negative schizotypy 
regression coefficients differed significantly). The most elegant method is to examine whether 
the 95% CIs around one standardized coefficient include the other coefficient. In other words, if 
the 95% CI around the beta for positive schizotypy’s prediction of psychotic-like experiences 
does not include the beta value for negative schizotypy, we can reject that null that β positive = β 
negative. However, MPlus does not provide bootstrapped CIs for standardized coefficients (beta) 
in its output. As a solution, we computed nonbootstrapped CIs around the standardized 
coefficients and examined whether they overlapped. Note that this appears to be an acceptable 
solution given that (a) bootstrapping does not change the coefficient values, just the estimation of 
standard errors and (b) the statistical significance did not change for any of the regression 
coefficients when the bootstrapped and nonbootstrapped results were compared. The results with 
the nonbootstrapped CIs are presented in Supplemental Table S4. The betas for positive and 
negative schizotypy were significantly different for 14 of the 19 analyses. However, we caution 
readers to consider the larger pattern of findings across multiple studies, given that this study was 
not specifically designed to assess the positive and negative schizotypy dimensions. 
Discussion 
Early psychiatric models suggested that psychosis represented a discontinuity such that one 
either did or did not have a psychotic illness (and “never the twain shall meet”). However, 
increasing evidence from multiple sources such as community studies (e.g., van Os, Hanssen, 
Bijl, & Ravelli, 2000), family studies (e.g., Kendler, McGuire, Gruenberg, & Walsh, 1995), and 
studies of the prodrome (e.g., Woods et al., 2009) and high-risk designs (e.g., Gooding, Tallent, 
& Matts, 2005) indicates that brief, transient, and subclinical psychotic symptoms are not 
uncommon and that these symptoms may presage the development of schizophrenia-spectrum 
disorders. Schizotypy provides a powerful unifying framework for integrating subclinical 
manifestations, the prodrome, spectrum disorders, and full-blown psychosis. Schizotypy also 
allows us to consider risk and protective factors, facilitates the search for endophenotypes, and 
involves a multidimensional structure that takes into account the heterogeneous nature of 
etiology, expression, and treatment response. Furthermore, consideration of a multidimensional 
model of schizotypy should facilitate the mapping of psychosis and psychotic-like symptoms 
onto comprehensive models of psychopathology (e.g., Markon, 2010; Wright et al., 2013) and 
dimensional models of personality pathology (e.g., Krueger et al., 2011). However, reliable and 
valid measurement of these dimensions is essential for furthering our understanding of 
schizotypy and schizophrenia. 
The concurrent validity of psychometrically assessed positive and negative schizotypy has been 
supported in interview, questionnaire, laboratory, and daily life studies. However, the present 
findings provided the first evidence of the predictive validity of these dimensions by 
demonstrating that positive and negative schizotypy are associated with hypothesized patterns of 
symptoms and impairment in a 10-year follow-up of nonclinically ascertained young adults. The 
Chapmans’ longitudinal data set provides an ideal starting place for assessing the predictive 
validity of the dimensions because of its large sample size, high reassessment rate, 10-year time 
interval, and inclusion of criteria relevant to the construct of schizotypy. Although the results are 
not completely surprising in light of the findings for the individual scales in Chapman et al. 
(1994) and Kwapil(1998), the present findings make a unique contribution over those original 
results by assessing and supporting the validity of a conceptually driven dimensional model of 
schizotypy. Nevertheless, new prospective studies should be launched to attempt to replicate 
these findings in independent samples. Furthermore, such future studies would benefit from 
inclusion of measures of negative symptoms and the prodrome, as well as consideration of other 
schizotypy dimensions such as cognitive and behavioral disorganization. However, given the 
cost and time required to conduct longitudinal assessments, use of the Chapman’s longitudinal 
sample provided a unique opportunity to assess the validity of the positive and negative 
dimensions to predict psychopathology and impairment, and most importantly, the development 
of schizophrenia-spectrum disorders at the 10-year follow-up. 
As hypothesized, the dimensions showed differential patterns of associations at both the initial 
and follow-up assessments, such that positive schizotypy was associated with psychotic-like 
symptoms, mood disorders, substance abuse, and mental health treatment, whereas negative 
schizotypy was related to schizoid traits and diminished closeness of significant relationships. 
Furthermore, additional analyses indicated that positive schizotypy predicted the development of 
psychotic disorders and both dimensions predicted the development of schizophrenia-spectrum 
disorders over-and-above family history of psychosis. As expected, both dimensions were 
associated with schizotypal and paranoid traits and impaired functioning. These findings are 
consistent with Kwapil et al.’s (2008) cross-sectional interview study of 430 young adults, but 
also provide evidence that these dimensions are useful in longitudinally predicting 
schizophrenia-spectrum disorders. The results also indicated that the dimensions provided 
superior prediction relative to the original nominal groups used in Chapman et al. (1994). 
Converging evidence indicates that positive and negative schizotypy are related but qualitatively 
different phenotypes, with different etiologies and underlying pathophysiology. Despite this, 
researchers often treat schizotypy and schizophrenia as homogenous constructs. We suggest that 
failure to differentiate the multidimensional structure of schizotypy and schizophrenia will 
confound signal and noise and impede our ability to elucidate relevant etiological factors. 
Consistent with previous findings in the schizotypy literature (e.g., Miettunen & Jääskeläinen, 
2010; Raine, 1992), women scored higher than men on the positive schizotypy dimension (small 
effect size) and men scored higher on the negative schizotypy dimension (medium effect size). 
However, these gender differences did not account for the association of the positive and 
negative schizotypy dimensions with measures of symptoms and impairment at the cross-
sectional or longitudinal assessments. Note that the analyses of gender differences and effects in 
this study should be interpreted cautiously as these were largely post hoc examinations and the 
study was not specifically designed to examine gender differences. 
The positive and negative schizotypy dimensions predicted schizophrenia-spectrum symptoms 
and disorders at the 10-year follow-up. An obvious concern is that this may simply reflect 
baseline effects at the initial assessment; however, several factors speak against this. First, the 
participants were all functioning well enough at the initial assessment to attend a major 
university and had only just entered the age of greatest risk for developing spectrum disorders. 
As noted, both schizotypy dimensions predicted psychotic-like, schizotypal, and paranoid ratings 
at the follow-up over-and-above ratings at the initial interview. In terms of disorders, none of the 
participants met criteria for psychotic illnesses at the initial assessment, although 14 had done so 
at the time of the follow-up. Unfortunately, Chapman et al. (1994) did not diagnose 
schizophrenia-spectrum personality disorders at the initial assessment, so we cannot definitively 
state the extent to which spectrum personality disorders diagnosed at the follow-up assessment 
were present at the initial assessment. However, several lines of evidence suggest that the rates at 
the initial assessment would likely be low. Using a subset of 180 participants from the Chapman 
et al. study, Kwapil (1998) used extant information to make DSM–III–R schizotypal, schizoid, 
and paranoid personality disorder diagnoses for participants at the initial assessment. Only one of 
180 (.6%) met criteria for a schizophrenia-spectrum personality disorder diagnosis at the initial 
assessment. Similarly, two cross-sectional interview studies assessed large samples of college 
students with an overrepresentation of high scorers on the positive and negative schizotypy 
dimensions. Kwapil et al. (2008) reported that only seven of 430 (1.6%) met criteria for 
schizotypal, schizoid, or paranoid personality disorders, and Barrantes-Vidal et al. 
(2013) reported a rate of five of 214 (2.3%) for these disorders. So, the evidence suggests that the 
dimensions predicted symptoms at the cross-sectional assessment and the development of 
symptoms and disorders at the follow-up assessment. 
Chapman et al. (1994) reported that their group identified by high scores on the Physical 
Anhedonia Scale did not have elevated rates of psychotic disorders, elevated ratings of 
psychotic-like or schizophrenia-spectrum personality disorder traits, or impaired functioning 
compared with the control group at the follow-up assessment. In contrast, the negative 
schizotypy dimension, which includes comparable loadings from both anhedonia scales, was 
significantly associated with schizophrenia-spectrum disorders, symptoms, and impairment 
(over-and-above variance accounted for by positive schizotypy). Furthermore, the findings for 
the negative schizotypy dimensional score are as good or superior to the findings for the Revised 
Social Anhedonia Scale reported by Kwapil (1998), suggesting that the effectiveness of the 
Revised Social Anhedonia Scale as a predictor is not “diluted” by the inclusion of variance from 
the Physical Anhedonia Scale. We suggest that the combination of variance from the two 
anhedonia scales provides a richer assessment of the negative schizotypy dimension than either 
scale individually. 
The finding that the positive and negative schizotypy interaction term generally did not account 
for additional variance is consistent with our previous studies and suggests that the effects of the 
dimensions tend to be additive. This additive effect is clearly demonstrated in Barrantes-Vidal, 
Lewandowski, and Kwapil’s (2010) findings of marked deviancy for a combined positive and 
negative schizotypy cluster. Of note, significant interactions were found at both assessments for 
measures of paranoia—despite the fact that these were assessed 10 years apart and that the initial 
assessment used a trait-based questionnaire of paranoia, whereas the follow-up used an interview 
for paranoid personality disorder. It is not entirely clear why this interaction occurred specifically 
for paranoia. Bentall et al. (2009) described that paranoia has a wide variety of emotional (e.g., 
negative affect, low self-esteem) and social–cognitive (e.g., poor ability to reason about the 
mental states of others) mechanisms that appear to be differentially related to positive and 
negative schizotypy. Thus, high levels of paranoia may require this synergistic combination of 
affective and cognitive deficits associated with positive and negative schizotypy. However, this 
bears further investigation in both cross-sectional and longitudinal studies. 
One possible criticism is that the assignment of factor scores for positive and negative schizotypy 
involved the use of formulae based on college students norms from data collected in another 
state and approximately two decades after the participants in the Chapmans’ sample were 
assessed. Unfortunately, it was not possible to assess the factor structure of the screening cohort 
from which the longitudinal samples was drawn. However, we have found that the factor 
structure is robust and invariant across time, location, and language. In fact, the factor scores 
from our formulae correlated .999 with factor scores derived from principal component analyses 
of recent samples collected in Spain (Kwapil, Ros-Morente, et al., 2012) and from unpublished 
data collected in Wisconsin in the early 1990s. Obviously, the most robust demonstration of the 
utility of the dimension scores comes from the validity findings in the present and recent studies. 
An additional concern is that the differential findings for positive and negative schizotypy are 
simply due to psychometric differences in discriminating power between the dimensions. 
However, we believe that is not the case. The schizotypy dimensions have been replicated in 
both exploratory and confirmatory factor studies. The factor structure is stable, and both factors 
account for a large portion of the variance in the underlying measures. Furthermore, the 
individual scales used to derive the factors all have good internal consistency and test–retest 
reliability. Second, Gross et al. (2013) reported that the 10-week test–retest reliabilities of the 
positive and negative schizotypy dimensions are .81 and .82, respectively. Furthermore, it is 
important to note that the present findings are part of a larger series of studies that have reported 
hypothesized differential patterns of associations of the positive and negative schizotypy 
dimensions with questionnaire, interview, biobehavioral, and daily life experiences. If the results 
were simply due to one of the dimensions being more psychometrically discriminating, we 
would expect to primarily find significant effects for that dimension. 
In summary, we believe that advancement of our understanding of schizotypy and schizophrenia 
requires conceptual and empirical consideration of the underlying multidimensional structure of 
these constructs. In turn, this requires reliable and valid measurement of these dimensions. The 
present study provided the first evidence of the predictive validity of psychometrically assessed 
positive and negative schizotypy, and it points the way for continued conceptualization and 
validation. 
Footnotes 
1 Unpublished test copies of the Revised Social Anhedonia Scale are available from the 
corresponding author Thomas R. Kwapil. 
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